Atherosclerosis imaging in drug development

Bibliography

• CHAMBLESS LE, HEISS G, FOLSOM AR et al.: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) study, 1987 – 1993. Am. J. Epidemiol. (1997) 146:483-494.
   PubMed Web of Science ®Google Scholar
• LORENZ MW, MARKUS HS, BOTS ML, ROSVALL M, SITZER M: Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation (2007) 115:459-467.
   PubMed Web of Science ®Google Scholar
• KANG S, WU Y, LI X: Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis (2004) 177:433-442.
   PubMed Web of Science ®Google Scholar
• SMILDE TJ, VAN WISSEN S, WOLLERSHEIM H, TRIP MD, KASTELEIN JJ, STALENHOEF AF: Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet (2001) 357:577-581.
   PubMed Web of Science ®Google Scholar
• TAYLOR AJ, KENT SM, FLAHERTY PJ, COYLE LC, MARKWOOD TT, VERNALIS MN: ARBITER: arterial biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation (2002) 106:2055-2060.
   PubMed Web of Science ®Google Scholar
• CROUSE JR III, RAICHLEN JS, RILEY WA et al.: Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR trial. JAMA (2007) 297:1344-1353.
   PubMed Web of Science ®Google Scholar
• TAYLOR AJ, SULLENBERGER LE, LEE HJ, LEE JK, GRACE KA: Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation (2004) 110:3512-3517.
   PubMed Web of Science ®Google Scholar
• KASTELEIN JJ, VAN LEUVEN SI, BURGESS L et al.: Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N. Engl. J. Med. (2007) 356:1620-1630.
   PubMed Web of Science ®Google Scholar
• BALLANTYNE CM: Clinical trial endpoints: angiograms, events, and plaque instability. Am. J. Cardiol. (1998) 82:M5-M11.
   PubMedGoogle Scholar
• BROWN BG, ZHAO XQ, CHAIT A et al.: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N. Engl. J. Med. (2001) 345:1583-1592.
   PubMed Web of Science ®Google Scholar
• NO AUTHORS LISTED: Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation (1983) 68:939-950.
   PubMed Web of Science ®Google Scholar
• AMBROSE JA, TANNENBAUM MA, ALEXOPOULOS D et al.: Angiographic progression of coronary artery disease and the development of myocardial infarction. J. Am. Coll. Cardiol. (1988) 12:56-62.
   PubMed Web of Science ®Google Scholar
• FALK E, SHAH PK, FUSTER V: Coronary plaque disruption. Circulation (1995) 92:657-671.
   PubMed Web of Science ®Google Scholar
• GLAGOV S, WEISENBERG E, ZARINS CK, STANKUNAVICIUS R, KOLETTIS GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med. (1987) 316:1371-1375.
   PubMed Web of Science ®Google Scholar
• SCHOENHAGEN P, ZIADA KM, VINCE DG, NISSEN SE, TUZCU EM: Arterial remodeling and coronary artery disease: the concept of “dilated” versus “obstructive” coronary atherosclerosis. J. Am. Coll. Cardiol. (2001) 38:297-306.
   PubMed Web of Science ®Google Scholar
• MINTZ GS, KENT KM, PICHARD AD, POPMA JJ, SATLER LF, LEON MB: Intravascular ultrasound insights into mechanisms of stenosis formation and restenosis. Cardiol. Clin. (1997) 15:17-29.
   PubMedGoogle Scholar
• KAPADIA SR, NISSEN SE, TUZCU EM: Impact of intravascular ultrasound in understanding transplant coronary artery disease. Curr. Opin. Cardiol. (1999) 14:140-150.
   PubMed Web of Science ®Google Scholar
• NICHOLLS SJ, TUZCU EM, CROWE T et al.: Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J. Am. Coll. Cardiol. (2006) 47:1967-1975.
   PubMed Web of Science ®Google Scholar
• VON BIRGELEN C, HARTMANN M, MINTZ GS, BAUMGART D, SCHMERMUND A, ERBEL R: Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or = 12 months) follow-up intravascular ultrasound. Circulation (2003) 108:2757-2762.
   PubMed Web of Science ®Google Scholar
• SCHARTL M, BOCKSCH W, KOSCHYK DH et al.: Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation (2001) 104:387-392.
   PubMed Web of Science ®Google Scholar
• NISSEN SE, TUZCU EM, SCHOENHAGEN P et al.: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA (2004) 291:1071-1080.
   PubMed Web of Science ®Google Scholar
• NISSEN SE, TUZCU EM, SCHOENHAGEN P et al.: Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N. Engl. J. Med. (2005) 352:29-38.
   PubMed Web of Science ®Google Scholar
• NISSEN SE, NICHOLLS SJ, SIPAHI I et al.: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA (2006) 295:1556-1565.
   PubMed Web of Science ®Google Scholar
• OKAZAKI S, YOKOYAMA T, MIYAUCHI K et al.: Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study. Circulation (2004) 110:1061-1068.
   PubMed Web of Science ®Google Scholar
• JENSEN LO, THAYSSEN P, PEDERSEN KE, STENDER S, HAGHFELT T: Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation (2004) 110:265-270.
   PubMed Web of Science ®Google Scholar
• NICHOLLS SJ, TUZCU EM, SIPAHI I et al.: Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA (2007) 297:499-508.
   PubMed Web of Science ®Google Scholar
• NISSEN SE, TSUNODA T, TUZCU EM et al.: Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA (2003) 290:2292-2300.
   PubMed Web of Science ®Google Scholar
• TARDIF JC, GREGOIRE J, L'ALLIER PL et al.: Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA (2007) 297:1675-1682.
   PubMed Web of Science ®Google Scholar
• NISSEN SE, TARDIF JC, NICHOLLS SJ et al.: Effect of torcetrapib on the progression of coronary atherosclerosis. N. Engl. J. Med. (2007) 356:1304-1316.
   PubMed Web of Science ®Google Scholar
• NISSEN SE, TUZCU EM, LIBBY P et al.: Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA (2004) 292:2217-2225.
   PubMed Web of Science ®Google Scholar
• SIPAHI I, TUZCU EM, SCHOENHAGEN P et al.: Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J. Am. Coll. Cardiol. (2006) 48:833-838.
   PubMed Web of Science ®Google Scholar
• RUDEL LL, LEE RG, PARINI P: ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. (2005) 25:1112-1118.
   PubMed Web of Science ®Google Scholar
• TARDIF JC, GREGOIRE J, L'ALLIER PL et al.: Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation (2004) 110:3372-3377.
   PubMed Web of Science ®Google Scholar
• NISSEN SE, TUZCU EM, BREWER HB et al.: Effect of ACAT inhibition on the progression of coronary atherosclerosis. N. Engl. J. Med. (2006) 354:1253-1263.
   PubMed Web of Science ®Google Scholar
• EISEN HJ, TUZCU EM, DORENT R et al.: Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N. Engl. J. Med. (2003) 349:847-858.
   PubMed Web of Science ®Google Scholar
• HAUSMANN D, ERBEL R, ALIBELLI-CHEMARIN MJ et al.: The safety of intracoronary ultrasound. A multicenter survey of 2207 examinations. Circulation (1995) 91:623-630.
   PubMed Web of Science ®Google Scholar
• GUEDES A, KELLER PF, L'ALLIER PL, LESPERANCE J, GREGOIRE J, TARDIF JC: Long-term safety of intravascular ultrasound in nontransplant, nonintervened, atherosclerotic coronary arteries. J. Am. Coll. Cardiol. (2005) 45:559-564.
   PubMed Web of Science ®Google Scholar
• BATKOFF BW, LINKER DT: Safety of intracoronary ultrasound: data from a multicenter European registry. Cathet. Cardiovasc. Diagn. (1996) 38:238-241.
   PubMedGoogle Scholar
• RAMASUBBU K, SCHOENHAGEN P, BALGHITH MA et al.: Repeated intravascular ultrasound imaging in cardiac transplant recipients does not accelerate transplant coronary artery disease. J. Am. Coll. Cardiol. (2003) 41:1739-1743.
   PubMed Web of Science ®Google Scholar
• NAIR A, KUBAN BD, TUZCU EM, SCHOENHAGEN P, NISSEN SE, VINCE DG: Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation (2002) 106:2200-2206.
   PubMed Web of Science ®Google Scholar
• KAWASAKI M, SANO K, OKUBO M et al.: Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J. Am. Coll. Cardiol. (2005) 45:1946-1953.
   PubMed Web of Science ®Google Scholar
• GREENLAND P, LABREE L, AZEN SP, DOHERTY TM, DETRANO RC: Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA (2004) 291:210-215.
   PubMed Web of Science ®Google Scholar
• PLETCHER MJ, TICE JA, PIGNONE M, BROWNER WS: Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch. Intern. Med. (2004) 164:1285-1292.
   PubMed Web of Science ®Google Scholar
• ACHENBACH S, ROPERS D, POHLE K et al.: Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation (2002) 106:1077-1082.
   PubMed Web of Science ®Google Scholar
• RAGGI P, DAVIDSON M, CALLISTER TQ et al.: Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: beyond endorsed lipid lowering with EBT scanning (BELLES). Circulation (2005) 112:563-571.
   PubMed Web of Science ®Google Scholar
• SCHMERMUND A, ACHENBACH S, BUDDE T et al.: Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation (2006) 113:427-437.
   PubMed Web of Science ®Google Scholar
• NICHOLLS SJ, TUZCU EM, WOLSKI K et al.: Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J. Am. Coll. Cardiol. (2007) 49:263-270.
   PubMed Web of Science ®Google Scholar
• ACHENBACH S, ROPERS D, POHLE FK et al.: Detection of coronary artery stenoses using multi-detector CT with 16 × 0.75 collimation and 375 ms rotation. Eur. Heart J. (2005) 26:1978-1986.
   PubMed Web of Science ®Google Scholar
• SALM LP, BAX JJ, JUKEMA JW et al.: Comprehensive assessment of patients after coronary artery bypass grafting by 16-detector-row computed tomography. Am. Heart J. (2005) 150:775-781.
   PubMed Web of Science ®Google Scholar
• WORTHLEY SG, HELFT G, FUSTER V et al.: Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. Circulation (2000) 101:2956-2961.
   PubMed Web of Science ®Google Scholar
• FAYAD ZA, NAHAR T, FALLON JT et al.: In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation (2000) 101:2503-2509.
   PubMed Web of Science ®Google Scholar
• CORTI R, FAYAD ZA, FUSTER V et al.: Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation (2001) 104:249-252.
   PubMed Web of Science ®Google Scholar
• CORTI R, FUSTER V, FAYAD ZA et al.: Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation (2002) 106:2884-2887.
   PubMed Web of Science ®Google Scholar
• CORTI R, FUSTER V, FAYAD ZA et al.: Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J. Am. Coll. Cardiol. (2005) 46:106-112.
   PubMed Web of Science ®Google Scholar
• HATSUKAMI T, ZHAO X-Q, KRAUSS LW: Assessment of rosuvastatin treatment on carotid atherosclerosis in moderately hypercholesterolemic subjects using high-resolution magnetic resonance imaging. Eur. Heart J. (2005) 26:626.
   Google Scholar